pioglitazone has been researched along with Abnormalities, Autosome in 3 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pioglitazone is a prototype of thiazolidinediones, used for the treatment of type 2 diabetes mellitus." | 1.38 | Evaluation of vitamin B12 effects on DNA damage induced by pioglitazone. ( Al-Azzam, S; Alzoubi, K; Hussain, N; Khabour, O; Mhaidat, N, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oz Gul, O | 1 |
| Cinkilic, N | 1 |
| Gul, CB | 1 |
| Cander, S | 1 |
| Vatan, O | 1 |
| Ersoy, C | 1 |
| Yılmaz, D | 1 |
| Tuncel, E | 1 |
| Yokote, K | 1 |
| Saito, Y | 1 |
| Alzoubi, K | 1 |
| Khabour, O | 1 |
| Hussain, N | 1 |
| Al-Azzam, S | 1 |
| Mhaidat, N | 1 |
3 other studies available for pioglitazone and Abnormalities, Autosome
| Article | Year |
|---|---|
Comparative genotoxic and cytotoxic effects of the oral antidiabetic drugs sitagliptin, rosiglitazone, and pioglitazone in patients with type-2 diabetes: a cross-sectional, observational pilot study.
Topics: Aged; Blood Glucose; Chromosome Aberrations; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Fem | 2013 |
Extension of the life span in patients with Werner syndrome.
Topics: Adult; Chromosome Aberrations; Disease Progression; Genes, Recessive; Humans; Hydroxymethylglutaryl- | 2008 |
Evaluation of vitamin B12 effects on DNA damage induced by pioglitazone.
Topics: Adult; Antimutagenic Agents; Chromosome Aberrations; DNA Damage; Humans; Hypoglycemic Agents; Male; | 2012 |